BFM
FTH

Boothbay Fund Management’s Faeth Therapeutics FTH Stock Holding History

Boothbay Fund Management’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$823K Buy
+26,124
New +$522K 0.01% 1045
2025
Q2 		– Sell
-5,433
Closed -$42.8K – 1746
2025
Q1 		$42.8K Sell
5,433
-3,207
-37% -$30.5K ﹤0.01% 1293
2024
Q4 		$84.7K Sell
8,640
-2
-0% -$20 ﹤0.01% 1308
2024
Q3 		$103K Hold
8,642
– – ﹤0.01% 1456
2024
Q2 		$107K Buy
+8,642
New +$180K ﹤0.01% 1343

Other funds holding FTH

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Boothbay Fund Management's FTH Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Faeth Therapeutics (FTH) in Q1 2026: 26,124 shares worth $823K. The stake represents 0.01% of the portfolio and ranks #1045 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in FTH as recently as Q1 2025.

Boothbay Fund Management first reported a position in FTH in Q2 2024 and has held it in 5 quarters since. 30 funds tracked by Wall St. Rank hold FTH as of Q1 2026.

  • Boothbay Fund Management held 26,124 shares of Faeth Therapeutics worth $823K as of Q1 2026.
  • Faeth Therapeutics was a new Boothbay Fund Management position in Q1 2026.
  • Faeth Therapeutics made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1045 holding.
  • Boothbay Fund Management first reported a position in Faeth Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 30 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.